The Claim
In obese women aged 20–45, slow and moderate weight loss reduces plasma interleukin-1 (IL-1) significantly more than rapid weight loss, but neither slow, moderate, nor rapid weight loss significantly reduces high-sensitivity C-reactive protein (hs-CRP) from baseline, indicating that IL-1 is more responsive to the rate of weight loss than hs-CRP.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese women aged 20–45, losing weight slowly or at a moderate pace lowers plasma interleukin-1 levels more than losing weight quickly, but none of these weight loss speeds significantly lower high-sensitivity C-reactive protein levels, suggesting that interleukin-1 responds more to how fast weight is lost than high-sensitivity C-reactive protein does.
See the scientific wording
In obese women aged 20–45, slow and moderate weight loss reduce plasma interleukin-1 (IL-1) significantly more than rapid weight loss, but neither approach significantly reduces high-sensitivity C-reactive protein (hs-CRP) from baseline, suggesting IL-1 is more responsive to weight loss speed than hs-CRP.
What the research says
1 studyThe study found that slow weight loss actually lowered a key inflammation marker (hs-CRP) more than fast weight loss, which goes against the claim that it doesn’t change. It also didn’t show that IL-1 dropped significantly from the start, even though the claim said it did. So the results don’t match the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.